FDA Granted Fast Track Designation for Genervon's Breakthrough...

In a huge victory for ALS sufferers, FDA granted Genervon Biopharmaceuticals a fast track designation for its first in class highly effective multi-target master regulator biotechnology drug GM604 for ALS.

http://technews.tmcnet.com/news/2013/06/26/7235439.htm